146 related articles for article (PubMed ID: 1400473)
1. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
3. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
[TBL] [Abstract][Full Text] [Related]
5. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
[TBL] [Abstract][Full Text] [Related]
6. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
7. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
[TBL] [Abstract][Full Text] [Related]
9. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
[TBL] [Abstract][Full Text] [Related]
10. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
Walsh A; Ito Y; Breslow JL
J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
Kalopissis AD; Chambaz J
Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356
[TBL] [Abstract][Full Text] [Related]
12. SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism.
de Beer MC; van der Westhuyzen DR; Whitaker NL; Webb NR; de Beer FC
J Lipid Res; 2005 Oct; 46(10):2143-50. PubMed ID: 16061955
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of HDL deficiency in mice overexpressing human apoA-II.
Julve J; Escolà-Gil JC; Ribas V; González-Sastre F; Ordóñez-Llanos J; Sánchez-Quesada JL; Blanco-Vaca F
J Lipid Res; 2002 Oct; 43(10):1734-42. PubMed ID: 12364558
[TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism affecting apolipoprotein A-II translational efficiency determines high density lipoprotein size and composition.
Doolittle MH; LeBoeuf RC; Warden CH; Bee LM; Lusis AJ
J Biol Chem; 1990 Sep; 265(27):16380-8. PubMed ID: 2118905
[TBL] [Abstract][Full Text] [Related]
16. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover.
Silver DL; Jiang XC; Tall AR
J Biol Chem; 1999 Feb; 274(7):4140-6. PubMed ID: 9933608
[TBL] [Abstract][Full Text] [Related]
17. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
[TBL] [Abstract][Full Text] [Related]
18. Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat.
Tall AR; Blum CB; Forester GP; Nelson CA
J Biol Chem; 1982 Jan; 257(1):198-207. PubMed ID: 6796585
[TBL] [Abstract][Full Text] [Related]
19. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
Hedrick CC; Castellani LW; Wong H; Lusis AJ
J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
[TBL] [Abstract][Full Text] [Related]
20. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
Rubin EM; Ishida BY; Clift SM; Krauss RM
Proc Natl Acad Sci U S A; 1991 Jan; 88(2):434-8. PubMed ID: 1703299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
